Anthera Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Anthera Pharmaceuticals, Inc.
European Probiotics specialist Probi has acquired a stake in US supplements firm Vital Nutrients, in a deal which will see the companies collaborate on new product development.
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
Probi's probiotic "significantly decreased" plasma levels of two inflammatory markers coupled to acute stress in study, with the firm planning further research into the gut-brain axis.
EU Business Round-Up: Probi Targets Acquisitions, Oystershell Heads To US, Doetsch Grether Inks Swiss Deal
Probiotics player Probi will use deals and organic growth to double its sales over five years; Belgium's Oysershell strikes deal with Bayer for head-lice brand; and Doetsch Grether acquires Swiss supplements firm Vita.
- Large Molecule
- Other Names / Subsidiaries
- Alkira Therapeutics, Inc.